EGFR kinase inhibitor 2
EGFR kinase inhibitor 2 (compound A-7) is a potent EGFR inhibitor targeting EGFRL858R/T790M/C797S and EGFRDel19/T790M/C797S mutants. EGFR kinase inhibitor 2 has the potential to address acquired resistance in the treatment of non-small cell lung cancer.
For research use only. We do not sell to patients.
- Formula: C39H40N6O5
- Molecular Weight:672.77
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
EGFRL858R/T790M/C797S, EGFRDel19/T790M/C797S[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| NCI-H1975 | IC50 |
11 μM
Compound: A-7
|
Anticancer activity against human NCI-H1975 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Anticancer activity against human NCI-H1975 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 37952262] |
Chemical Information
-
Molecular Weight 672.77
-
Formula C39H40N6O5
-
SMILES
COC1=C(C=C2C(N=CN=C2NCC3=CC=C(C=C3)NC(C(N4CC5=C(C4=O)C=CC=C5)C6=CC=CC=C6)=O)=C1)OCCCN7CCOCC7
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)